Intimation Regarding Non-Submission Of Financial Results For The Quarter Ended June 30, 2026 Due To Ongoing CIRP.
A routine update. Use the price and stock snapshot to gauge how the market is responding.
Glenmark PharmaceuticalsGlenmark Pharmaceuticals Limited — Options to purchase securities
NSE · 1 hr ago
Akums Drugs and PharmaceuticalsAkums Drugs and Pharmaceuticals Limited — Monitoring Agency Report
NSE · 1 hr ago
Liberty ShoesLiberty Shoes Limited — Outcome of Board Meeting
NSE · 1 hr ago
Net Avenue TechnologiesNet Avenue Technologies Limited — Shareholders meeting
NSE · 1 hr ago
Gateway DistriparksGateway Distriparks Limited — Analysts/Institutional Investor Meet/Con. Call Updates
NSE · 1 hr ago
Jash EngineeringJash Engineering Limited — Bagging/Receiving of orders/contracts (Sub-para 4-Para B)
NSE · 1 hr ago
NescoNesco Limited — Analysts/Institutional Investor Meet/Con. Call Updates
NSE · 1 hr ago
Eris LifesciencesEris Lifesciences Limited — Analyst/Investor Meet Para A-XBRL
NSE · 1 hr ago
The Phoenix MillsThe Phoenix Mills Limited — Acquisition (including agreement to acquire)-XBRL
NSE · 1 hr ago
Hindustan Copper Q1 Results: PAT zooms 163% YoY to Rs 353 crore; revenue rises to Rs 937 crore
Economic Times · 1 hr ago
Lower or nil TDS certificates to go fully online soon, rules being framed
Economic Times · 1 hr ago
Global Market: China bears the brunt of Asia’s crude oil demand cut as Middle East supplies shrink
Economic Times · 1 hr ago
Zee moves SAT against SEBI market ban, seeks relief to proceed with ₹3,143.5 crore fund raise
BusinessLine · 1 hr ago
Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.